Bioventus Inc. provided earnings guidance for the year 2024. For the year, the company expects net sales to be in the range of $520 million to $535 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | +2.21% | -3.43% | +22.77% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.77% | 404M | |
+75.69% | 12.57B | |
+8.49% | 6.66B | |
+15.10% | 5.5B | |
-18.30% | 4.88B | |
+14.96% | 4.1B | |
-20.83% | 3.89B | |
-28.50% | 2.83B | |
+43.74% | 2.31B | |
+1.98% | 2.07B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Inc. Provides Earnings Guidance for the Year 2024